NAFDAC, NHIA collaborate with local pharmaceutical manufacturers to solve out-of-stock syndrome

The National Food and Drug Administration and Control (NAFDAC) and the National Health Insurance Authority (NHIA) will be collaborating with local manufacturers to solve the out-of-stock syndrome in the nation’s health facilities.

This collaboration is in line with Executive Order 3 which requires that all ministries, departments and agencies responsible for paying suppliers shall grant preference to local manufacturers in their procurement of goods.

The NHIA will work with local pharmaceutical manufacturers whose manufacturing facilities have been approved by NAFDAC as meeting Good Manufacturing Practices (GMP) requirements for the procurement of the needed medicines.

Dr Christianah Adeyeye, DG of NAFDAC, disclosed that the NHIA has signed a memorandum of understanding with pharmaceutical companies and Drug management organisations for the production of 33 different drugs to address the recurring problem of out-of-stock syndrome in the nation’s healthcare facilities.